Clinical Leader - Helping clinical research professionals connect and collaborate

Glowing digital neural network-GettyImages-2233500411

Synaptic Regeneration And The Future Of Alzheimer's R&D

For too long, treating Alzheimer’s disease has been a case of “managed decline.” We need to move beyond slowing disease progression toward achieving tangible functional recovery.

GUEST COLUMNISTS

Contracting For AI In Clinical Trials: Cybersecurity, Monitoring, And Risk Allocation (Part 3)
Leibowitz Law shares the third installment of its three-part series on contracting for AI in clinical trial operations. Part 3 picks up with cybersecurity, monitoring and validation, and risk allocation.
Contracting For AI In Clinical Trials: Data Rights And Regulatory Compliance (Part 2)
Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 2 demonstrates why organizations must understand where it is used, how it interacts with data, and where the risks lie.
Where AI Appears In Clinical Trials — And Why Contracts Need To Catch Up (Part 1)
Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 1 outlines where AI appears in ClinOps and supporting technologies, and the questions companies and organizations should ask when AI touches data.
Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study
Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.
It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust
CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.
When AI Agents Start Researching Trials On Behalf Of Patients, What Happens?
Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.
The U.S. Clinical Trial Recruiting Pipeline Report – May 2026
This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from March 7 to May 1, 2026.
Safe And Scalable AI Deployment For Clinical Trials
When life sciences organizations lack a structured, evidence-based methodology for scaling AI tools safely and effectively, they put clinical development at risk. Partha Anbil and Partha Khot team up to share a practical approach to its implementation.

CLINICAL TRIAL WHITE PAPERS

Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls
This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

The Importance Of A Maturity Model For Clinical Trial Transparency
10/23/2024

A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.
The EMR Interoperability Dream Vs. Clinical Research Reality
10/20/2025

Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
Challenges, Opportunities For Recruitment In The Digital Age
10/20/2025

Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.
Decentralized And Community-Based Solutions Driving Women's Healthcare
9/24/2025

Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.
Strategies For Post-Approval Lifecycle Management And Local PV
7/12/2024

If you are unsure of how to navigate your post-approval regulatory journey, an experienced regulatory services partner can provide support to help you identify and achieve post-approval goals.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Recruiting & Retaining More Patients Per Site:
3/14/2025

Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
Paperless Online Remote Source Document Verification
2/2/2026

Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
Automated Trial Monitoring Workflows Make A Lean Team More Efficient
1/7/2026

A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
Reframing Clinical Vendor Selection
7/2/2025

Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.
How Syneos Health Tackles Protocol Complexities
1/7/2025

Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase I-IV clinical trials, particularly under a complex adaptive trial protocol.
From Months To Hours: MMC Medical's EDC Revolution
3/31/2026

Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

How Did You End Up In Clinical Research?

To commemorate Clinical Trials Day, we asked clinical researchers to share their story, answering, "How did you get into clinical research?"
When AI Agents Start Researching Trials On Behalf Of Patients, What Happens?

Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.
The U.S. Clinical Trial Recruiting Pipeline Report – May 2026

This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from March 7 to May 1, 2026.

FOCUS ON PATIENTS

Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study

Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.
It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust

CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.
Precision Medicine Needs Better Infrastructure — And We Already Have The Models For It

Standard methods for evaluating clinical trial representativeness perform poorly when the trial population differs from the broader disease population in a patient registry. June Cha, Ph.D., MPH, explains how the right metrics can make a difference.